Forensic assessment of maternal deaths from the COVID-19 during the 2021 pandemic

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

BACKGROUND: According to the literature, the mortality rate from SARS-CoV-2 infection among pregnant women is up to 25%. The high-risk group for the development of severe forms of COVID-19 includes pregnant women with extragenital pathology. Obstetric tactics are determined by the severity of the condition of the mother and fetus, as well as the duration of pregnancy. The decision on early delivery is made as a result of an interdisciplinary medical consultation. Delivery in the midst of the disease is associated with an increase in maternal mortality. According to the literature, including our own research, it has been established that the basis for favorable perinatal outcomes in patients with severe and moderate forms of COVID-19 is: an adequate assessment of the condition of the pregnant woman and fetus (especially at the outpatient stage, where the pregnant woman goes first), early hospitalization, early initiation of intensive care and timely delivery before the onset of irreversible organ changes in pregnant women.

AIM: The aim of this study was to analyze the tactics of pregnancy management, delivery and perinatal outcomes, assessing the quality of medical care at the outpatient and hospital stages provided to pregnant women who died in a specialized obstetric hospital from the extremely severe new coronavirus infection COVID-19 (based on the data of commission forensic examinations).

MATERIALS AND METHODS: This retrospective study of pregnancy outcomes was performed in 11 patients who died from complications of extremely severe COVID-19 in a regional specialized obstetric hospital in Russia based on the data of commission forensic examinations performed in the Bureau of Forensic Medical Examination (Saint Petersburg, Russia) in 2021, at gestation periods of 28–34 weeks (n = 7) and 37–39 weeks (n = 4) in the context of assessing the quality of medical care in the field of obstetrics and gynecology. We confirmed the diagnosis of the new coronavirus infection COVID-19 in 10 (90.9%) patients by SARS-CoV-2 RNA identification using polymerase chain reaction in a nasopharyngeal smear on an average of 4.9 ± 3.6 days from the onset of the disease. In one patient, the clinical diagnosis was confirmed postmortem by the detection of SARS-Cov-2 RNA during autopsy (in the trachea, lungs, and spleen). All patients in the hospital underwent a comprehensive anamnestic, clinical and laboratory examination in the amount regulated by the administrative regulations of the Ministry of Health of the Russian Federation that were relevant at the time of providing medical care. Nine (81.8%) patients sought medical help from a local therapist on 3.1 ± 1.6 days from the onset of the disease and received outpatient treatment for 3.4 ± 1.8 days, two patients not seeing a doctor and receiving outpatient care. The average time before admission to the specialized obstetric hospital was 6.0 ± 2.2 days from the onset of the disease.

RESULTS: During the forensic assessment of the medical records of deceased patients, significant defects in the quality of medical care were identified in the framework of this study at the stages of information collection, diagnosis, treatment, and succession. An indirect causal relationship was established between the most significant defects in the quality of medical care and adverse pregnancy outcomes, since the cause of death or critical conditions were individually determined severe complications, rather than defects in medical care, which, nevertheless, does not exclude their significance in the totality of causes of severe maternal outcomes.

CONCLUSIONS: The data obtained indicate the need for earlier delivery in pregnant women with the new coronavirus infection COVID-19 before the appearance of irreversible changes in patients with progressive respiratory failure, multiple organ failure syndrome, systemic inflammatory response syndrome, and cytokine storm.

About the authors

Vitaly F. Bezhenar

Academician I.P. Pavlov First St. Petersburg State Medical University

Email: bez-vitaliy@yandex.ru
ORCID iD: 0000-0002-7807-4929
SPIN-code: 8626-7555

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Saint Petersburg

Irina A. Dobrovolskaya

Academician I.P. Pavlov First St. Petersburg State Medical University

Email: scusami@yandex.ru
ORCID iD: 0000-0002-9819-213X
SPIN-code: 4197-7150

MD, Cand. Sci. (Medicine)

Russian Federation, Saint Petersburg

Igor M. Nesterov

Academician I.P. Pavlov First St. Petersburg State Medical University

Author for correspondence.
Email: ignester@yandex.ru
ORCID iD: 0000-0002-7558-7657
SPIN-code: 4158-6201

MD, Cand. Sci. (Medicine), Assistant Professor

Russian Federation, Saint Petersburg

Olga A. Bykhovskaya

Bureau of Forensic Medicine

Email: sudmed@zdrav.spb.ru
ORCID iD: 0000-0002-6274-4529

MD, Cand. Sci. (Medicine)

Russian Federation, Saint Petersburg

Alla Ye. Nikolaeva

Academician I.P. Pavlov First St. Petersburg State Medical University

Email: alla-nikolaeva2007@yandex.ru
ORCID iD: 0000-0003-3802-5468

MD, Cand. Sci. (Medicine)

Russian Federation, Saint Petersburg

Ruslan I. Minnullin

Academician I.P. Pavlov First St. Petersburg State Medical University

Email: minn83@mail.ru
ORCID iD: 0009-0000-2264-8551

MD, Cand. Sci. (Medicine)

Russian Federation, Saint Petersburg

References

  1. On approval of criteria for assessing the quality of medical care. Order of the Ministry of Health of the Russian Federation dated May 10, 2017. N 203n. (In Russ.) [cited 2024 Feb 14]. Available from: https://rgk1rzn.ru/wp-content/uploads/2022/12/n203.pdf
  2. On approval of medical criteria for determining the severity of harm caused to human health. Order of the Ministry of Health and Social Development of the Russian Federation dated April 24, 2008 N 194n with amendments and additions dated January 18, 2012. (In Russ.) [cited 2024 Feb 14]. Available from: https://new.med.ru/sites/default/files/ docs/PMc_194n_24042008.pdf
  3. Bezhenar VF, Ailamazyan EK, Zazerskaya IE, et al. Brief clinical recommendations. Tactics for managing pregnant women, women in labor and postpartum with a new coronavirus infection (COVID-19). ICD-10: U07.2, U07.1 (version 2.0 dated 01.11.2021). Saint Petersburg: Eco-Vector; 2021. 58 p. (In Russ.)
  4. Organization of medical care for pregnant women, women in labor, postpartum women and newborns with a new coronavirus infection (COVID-19). Guidelines. Version 5 (14.02.2024). Moscow: Ministry of Health of the Russian Federation; 2021. 135 p. [cited 2024 Feb 14]. Available from: https://oms66.ru/upload/iblock/fd5/va2z9bp3ova08tfz3n70mgyk6l1ybyrg/BMP_preg_5.pdf
  5. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Temporary guidelines. Version 14 (27.12.2021). Moscow: Ministry of Health of the Russian Federation; 2021. 233 p. [cited 2024 Feb 14]. Available from: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/059/392/original/VMR_COVID-19_V15.pdf
  6. On approval of the Procedure for providing medical care in the field of obstetrics and gynecology. Order of the Ministry of Health of Russia dated October 20, 2020 N 1130n. Moscow: Ministry of Health of the Russian Federation, 2020. 802 p. [cited 2024 Feb 14]. Available from: https://embryo-ivf.ru/upload/normativ/prikaz_minzdrava_rossii_ot_20_10_2020_n_1130n.pdf
  7. Bezhenar VF, Nesterov IM, Dobrovolskaya IA. Perinatal outcomes of pregnancy and childbirth in moderate to severe COVID-19 patients. Journal of Obstetrics and Women’s Diseases. 2022;71(4):5–12. EDN: QVOLAB doi: 10.17816/JOWD105736
  8. Bezhenar VF, Romanova ML, Nesterov. IM, et al. Analyzing pregnancy course and outcomes in women with varying degrees of severity of the new coronavirus infection COVID-19 in Saint Petersburg: the lessons from pandemic. Obstetrics, Gynecology and Reproduction. 2022;16(4):365–380. EDN: TJCSGA doi: 10.17749/2313-7347/ob.gyn.rep.2022.314
  9. Bezhenar VF, Dobrovolskaya IA, Nesterov IM, et al. Opportunities for predicting adverse pregnancy outcomes in severe COVID-19. Obstetrics, Gynecology and Reproduction. 2023;17(1):75–91. EDN: VUKJOL doi: 10.17749/2313-7347/ob.gyn.rep.2023.338
  10. Bezhenar VF, Dobrovolskaya IA, Nesterov IM, et al. Pregnancy outcomes in moderate and severe forms of COVID-19. Effective Pharmacotherapy. 2022;18(7):12–18. (In Russ.) EDN: CITTFQ doi: 10.33978/2307-3586-2022-18-7-12-18
  11. Zazerskaya IE, Bezhenar VF, Godzoyeva AO, et al. Pneumonia in pregnant women with COVID-19: is it a new thrombotic microangiopathy in obstetric practice? Journal of Obstetrics and Women’s Diseases. 2020;69(4):29–40. EDN: GHMZPE doi: 10.17816/JOWD69429-40
  12. Dubrovina SO, Bezhenar VF, Alexandrina A.D., et al.; Dubrovina SO, Bezhenar VF, editors. Miscarriage: management tactics. Moscow: GEOTAR-Media; 2022. 576 p. (In Russ.) EDN: ZEXUCX doi: 10.33029/9704-6660-5-MMT-2022-1-576
  13. Eremeeva DR, Bezhenar VF, Zainulina MS, et al. Pathogenesis of COVID-19. Role of heparins in the therapy of severe conditions in patients with COVID-19. Obstetrics and Gynecology. 2020;(12):25–33. EDN: USMCRA doi: 10.18565/aig.2020.12.25-33
  14. Mannanova IV, Semenov VT, Ponezheva ZhB, et al. Clinical and laboratory characteristics of COVID-19. RMJ. 2021;29(4):22–25. EDN: UDCBNU
  15. Bezhenar’ VF, Zazerskaya IE. editors. Community-acquired pneumonia in pregnant women: differential diagnosis, treatment features, obstetric tactics in the context of the new coronavirus infection COVID-19 pandemic. ICD-10 (J13–J16 and J18; U07.1, U07.2): manual. Saint Petersburg: EkoVektor; 2020. 98 p. (In Russ.) [cited 2024 Feb 14]. Available from: https://journals.eco-vector.com/files/journals/7/sup_files/Vneb_Pnevm.pdf
  16. Dashraath P, Wong JLJ, Lim MXK, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020;222(6):521–531. doi: 10.1016/j.ajog.2020.03.021
  17. Wong SF, Chow KM, Leung TN, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191(1):292–297. doi: 10.1016/j.ajog.2003.11.019
  18. Jafari M, Pormohammad A, Neshin SAS, et al. Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: a systematic review and meta-analysis. Rev Med Virol. 2021;31(5):1–16. doi: 10.1002/rmv.2208.
  19. Bezhenar VF, Zazerskaya IE, Bettikher OA, et al. Controversial issues in obstetric management of women with novel coronavirus disease COVID-19 during pregnancy and childbirth. Obstetrics and Gynecology. 2020;(5):13–21. EDN: PPMNAW doi: 10.18565/aig.2020.5.13-21
  20. Figueiro-Filho EA, Yudin M, Farine D, COVID-19 during pregnancy: an overview of maternal characteristics, clinical symptoms, maternal and neonatal outcomes of 10,996 cases described in 15 countries. J Perinat Med. 2020;48(9):900–911. doi: 10.1515/jpm-2020-0364
  21. Dubey P, Reddy SY, Manuel S, et al. Maternal and neonatal characteristics and outcomes among COVID-19 infected women: An updated systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;252:490–501. doi: 10.1016/j.ejogrb.2020.07.034
  22. Belokrinitskaya TE, Artymuk NV, Filippov OS, et al. Maternal and perinatal outcomes during COVID-19 pandemia in far east and siberian federal region of Russia. Russian journal of Human Reproduction. 2021;7(2):130–136. EDN: RZCCZR doi: 10.17116/repro202127021130
  23. Vergara-Merino L, Meza N, Couve-Pérez C, et al. Maternal and perinatal outcomes related to COVID-19 and pregnancy: an overview of systematic reviews. Acta Obstet Gynecol Scand. 2021;100(7):1200–1218. doi: 10.1111/aogs.14118

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Timing of the fatal outcome in patients included in the study

Download (69KB)
3. Fig. 2. Terms of delivery by cesarean section in pregnant women with COVID-19

Download (95KB)

Copyright (c) 2024 Eсо-Vector



Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».